Perspectives in Eating Disorders
Adair Look, MD
“Emily,” a twenty-year-old college student, came to
treatment just after having attempted suicide by overdosing on old pain
medications she found in her parents’ bathroom. She admitted that,
before the attempt, she had become despondent over her unstoppable need
to chew large quantities of food and spit it out without ever swallowing
any of it. She was wasting away, now carrying only eighty pounds on her
five-foot, five-inch frame. Emily had been chewing and spitting out her
food as a way to soothe herself since the sixth grade but had never been
able to tell anyone because she was too embarrassed. “Who ever
heard of something so gross? I couldn’t tell anyone!” she
stated.
Emily is one of approximately five million people in the United
States who suffer from an eating
disorder, while many more suffer from disordered eating that borders on
a full-fledged disorder. In addition, eating disorders carry the highest
mortality risk of any psychiatric illness. Patients often come to
treatment for reasons seemingly unrelated to their eating disorders.
Although there is overlap in symptomotology, eating disorders are
currently categorized into three distinct diagnoses: anorexia nervosa
(AN), bulimia nervosa (BN), and eating disorder not otherwise specified
(EDNOS). Many patients, like Emily, do not fit neatly into these
categories.
“Sarah” was forty-two when
she presented to her internist with a concern for chronic halitosis.
After an exhaustive medical workup, Sarah finally admitted to
regurgitating her food two to three times per day. After her divorce ten
years prior, she began regurgitating her food from stress. She welcomed
its soothing effect and the fact that it made her weight easier to
manage, so she continued the behavior despite its inconvenience and its
effect on her breath. Sarah’s eating disorder, rumination, is far
more prevalent than most treaters are aware. Kjelsas shows in his 2004
article that 3% of young women have AN, 8% have BN, and about 14% meet
criteria for EDNOS. O’Brien (1995) and Fairburn (1984) showed that
17% to 33% of patients with BN engage in rumination at some time in
their history.
Regardless of the commonality of the
presenting symptoms, the immediate concerns in treating
eating-disordered patients include refeeding syndrome, metabolic
abnormalities, and cardiac abnormalities. Refeeding syndrome occurs when
underweight patients have starved themselves to the extent that their
cardiac tissue has atrophied, and when they are given increased fluids
and solids, their cardiac capacity becomes overloaded. This results in
dependent edema, tachycardia, increased jugular venous pressure, and
cardiac rhythm abnormalities.
Metabolic abnormalities can in fact help diagnose eating disorders,
as seen with “Kay.” Kay, a thirty-year-old woman, presented
with low body weight, a low potassium and high CO2, though she denied
vomiting to decrease caloric intake. A salivary amylase was drawn and
proved elevated, indicating repeated vomiting. Once confronted with the
results, Kay was able to admit to purging up to twelve times per
day.
Less immediate but equally damaging effects of eating disorders are
exemplified by “Alyssa,” a twenty-seven-year-old woman with
an eating disorder. Since age twelve, Alyssa has restricted calories and
excessively exercised. During her first year of law school, her weight
decreased to 92% of her ideal body weight (twenty pounds under normal
weight for her), and she sustained a femoral neck fracture. She was able
to normalize her weight over the next two years, but she then began
excessively exercising again and fractured the metatarsals in her left
foot. She suffers from female athletic triad: disordered eating,
amenorrhea, and osteoporosis. Three to 66% of female athletes are
affected, according to Yeager (1993).
The amenorrhea is hypothalamic in nature. During extreme stress,
whether physiologic or psychiatric, the hypothalamic-pituitary-adrenal
axis is activated to stop unnecessary bodily functions, resulting in
cessation of reproductive function. It is intended to be a
“protective mechanism” of the body, a reaction to stress. In
fact, increase in stress causes increase in amenorrhea in 100% of
prisoners prior to execution, as found by Chrousos (1998). In 2005,
Abraham showed that amenorrhea is also found in 24% of patients with
EDNOS and 15% of patients with bulimia.
Osteoporosis, the third aspect of female athletic triad, commonly
leads to bone fractures, as seen in the femoral neck fracture Alyssa
sustained. Anorexic patients often cite the fact that weight-bearing
exercise leads to increase in bone density. However, excessive
weight-bearing exercise leads to decrease in bone mineral density, and
osteoporosis often persists after weight restoration occurs and hormonal
levels normalize.
Mood disorders are common in eating-disordered patients, with
comorbid Axis I diagnoses in 73% of patients with AN and in 60% of
patients with BN (Herzog 1992). Recent research has focused on the
connection between eating disorders and mood, showing that serotonin is
involved in modulating impulsivity, obsessionality, mood, and appetite.
Patients with bulimia show a decrease in naturally occurring serotonin
and a decrease reactivity to serotonin. Patients with anorexia also show
a decrease in serotonin activity and reactivity, but these levels
increase after weight recovery has been achieved. "Pamela" was unable to
keep her weight above one hundred pounds, despite being five foot, nine
inches tall. She was also profoundly depressed and often contemplated
suicide. She was eventually able to increase her body weight because her
psychopharmacologist explained that SSRIs do not work as effectively on
underweight people and that a minimum body weight must be achieved for
full effect to occur.
Treatment of eating disorders is difficult. However, it is most
effective when using a multidisciplinary treatment team including a
psychopharmacologist, a therapist, a nutritionist, and a primary care
physician. There are currently limited psychopharmacologic interventions
for the treatment of eating disorders. Fluoxitine has been shown by to
decrease the urges to binge and to purge, as have desipramine and
imipramine (Becker 1998). Topamax has been shown to decrease the urge as
well, but it has the worrisome side effect of weight loss (Hedges 2003).
Anorexia has been more difficult to treat both pharmacologically and
therapeutically. Antipsychotics have begun to show promise with abnormal
or inaccurate body image issues, but nothing has been shown to treat the
underweight state of anorexia. Cognitive behavior therapy has proven to
be effective in improving the outcome of patients with BN but not with
AN.
Eating disorders carry with them a stigmatization that makes patients
ashamed of and secretive about their behavior. One tactic to engage them
in treatment is to isolate their illness as a force outside of their
person. "Angel" called her eating disorder “the it” and
gradually began to conceptualize it as an entity unto itself. She was
able to accept the support of her treatment team with the understanding
that “the it” was stronger than any one member of the
team—but that together, she and her treaters were stronger. Angel
was in treatment for seventeen years before she could eat out with her
family. She is well versed in the high relapse rate of patients with
eating disorders, but her committed relationship with her treatment team
has kept her alive through three ICU stays and two suicide attempts.
Often the triumphs of working with eating-disordered patients are
found in the small steps they achieve, such as eating more than one
thousand calories for seven days straight. At other times the rewards
are more remarkable: After eleven years of amenorrhea, Alyssa recently
gave birth to her first child.
Adair Look, MD, is an Attending Psychiatrist in the Women's
Health department of California
Pacific
Medical Center
|